Inborn metabolic
diseases are often thought of as the result of a single "disease"
allele, in contrast to a single "normal" allele. In
fact, most human gene loci are highly polymorphic, and there are
large numbers of variant alleles for medical conditions of
interest. An even greater range of variation remains
undetected, because most nucleotide substitutions (especially
third-position changes) do not noticeably affect gene activity.
Genetically-influenced traits in humans were first listed in
1966 in book form, Mendelian Inheritance in Man, which
grew from a slender single volume to a bulky two-volume 12th
edition in 1998 before it went entirely online as OMIM in 2004. Early
editions concerned phenotypically observable traits; the latest
editions make use of information in the Human Genome Project
and are strongly molecularly based.
In 2007, OMIM
listed 67 allelic
variants at the Phenylalanine Hydroxylase (PAH) locus
in the tables below.
Mutation |
# |
% |
Non-PKU
hyperphenylalanemia |
19 |
- |
Phenylketonuria (PKU) |
47 |
100 |
Splice-site
mutations |
7 |
14 |
Deletion
mutations, including: |
12 |
|
Complete
exon |
1 |
|
Single
triplet |
2 |
|
Five
triplets |
1 |
|
single
base => premature termination |
2 |
|
Non-sense
mutations |
9 |
18 |
Miss-sense mutations |
27 |
55 |
In the table below, XXX###YYY
describes a mis-sense substitution
of
amino acid XXX to YYY at position ###;
XXX###TER describes a termination (nonsense)
at position ###
IVS refers to an
alteration at an intervening spacer (intron)
DEL describes a deletion of a single 3bp triplet,
block of bps, or complete exon